Active, Not Recruiting
Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
NCT03813394
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infections, Head and Neck Neoplasms, +15 more
- Locations
-
- National University Hospital Singapore